The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking

Oligonucleotides

Volumn 20, Issue 2, 2010, Pages 103-109

  Alam, Md Rowshon ^a   Ming, Xin ^a   Dixit, Vidula ^a   Fisher, Michael ^a   Chen, Xiaoyuan ^b   Juliano, Rudolph L ^a  

^a University of North Carolina   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; ANTISENSE OLIGONUCLEOTIDE; ARGINYLGLYCYLASPARTIC ACID; BETA CYCLODEXTRIN; CHLORPROMAZINE; LUCIFERASE; METHYL BETA CYCLODEXTRIN; SMALL INTERFERING RNA; SPLICE SWITCHING ANTISENSE OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; MELANOMA CELL; PINOCYTOSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA SPLICING;

ACTINS; ANIMALS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; CELL LINE; ENDOCYTOSIS; FLUOROMETRY; HUMANS; MICROSCOPY, CONFOCAL; OLIGONUCLEOTIDES, ANTISENSE; RNA SPLICING;

EID: 77951957881     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0211     Document Type: Article

References (28)

1. ABES, S., MOULTON, H., TURNER, J., CLAIR, P., RICHARD, J.P., IVERSEN, P., GAIT, M.J., and LEBLEU, B. (2007). Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides. Biochem. Soc. Tra ns. 35, 53-55.
2. ALAM, M.R., DIXIT, V., KANG, H., LI, Z.B., CHEN, X., TREJO, J., FISHER, M., and JULIANO, R.L. (2008). Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis. Nucleic Acids Res. 36, 2764-2776.
3. APLIN, A.E., and JULIANO, R.L. (1999). Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J. Cell. Sci. 112(Pt 5), 695-706.
4. BENDIFALLAH, N., RASMUSSEN, F.W., ZACHAR, V., EBBESEN, P., NIELSEN, P.E., and KOPPELHUS, U. (2006). Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug. Chem. 17, 750-758.
5. CASTANOTTO, D., and ROSSI, J.J. (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature. 457, 426-433.
6. DAMM, E.M., PELKMANS, L., KARTENBECK, J., MEZZACASA, A., KURZCHALIA, T., and HELENIUS, A. (2005). Clathrin-and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J. Cell Biol. 168, 477-488.
7. DEAN, N.M., and BENNETT, C.F. (2003). Antisense oligonucleotide-based therapeutics for cancer. Oncogene. 22, 9087-9096.
8. EL-ANDALOUSSI, S., JOHANSSON, H.J., LUNDBERG, P., and LANGEL, U. (2006). Induction of splice correction by cell-penetrating peptide nucleic acids. J. Gene Med. 8, 1262-1273.
9. GEWIRTZ, A.M. (2007). On future's doorstep: RNA interference and the pharmacopeia of tomorrow. J. Clin. Invest. 117, 3612-3614.
10. KANG, H., ALAM, M.R., DIXIT, V., FISHER, M., and JULIANO, R.L. (2008). Cellular delivery and biological activity of antisense oli-gonucleotides conjugated to a targeted protein carrier. Bioconjug. Chem. 19, 2182-2188.
11. KHALIL, I.A., KOGURE, K., AKITA, H., and HARASHIMA, H. (2006). Uptake pathways and subsequent intracellular traff cking in nonviral gene delivery. Pharmacol. Rev. 58, 32-45.
12. KIRKHAM, M., and PARTON, R.G. (2005). Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim. Biophys. Acta. 1745, 273-286.
13. LI, S.D., CHEN, Y.C., HACKETT, M.J., and HUANG, L. (2008). Tumor-targeted delivery of siRNA by self-assembled nanopar-ticles. Mol. Ther. 16, 163-169.
14. LI, W., and SZOKA, F.C. Jr. (2007). Lipid-based nanoparticles for nucleic acid delivery. Pharm. Res. 24, 438-449.
15. MASSOL, R.H., LARSEN, J.E., FUJINAGA, Y., LENCER, W.I., and KIRCHHAUSEN, T. (2004). Cholera toxin toxicity does not require functional Arf6-and dynamin-dependent endocytic pathways. Mol. Biol. Cell. 15, 3631-3641.
16. MAYOR, S., and PAGANO, R.E. (2007). Pathways of clathrin-inde-pendent endocytosis. Nat. Rev. Mol. Cell Biol. 8, 603-612.
17. MEYER, M., PHILIPP, A., OSKUEE, R., SCHMIDT, C., and WAGNER, E. (2008). Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J. Am. Chem. Soc. 130, 3272-3273.
18. OSTAP, E.M., MAUPIN, P., DOBERSTEIN, S.K., BAINES, I.C., KORN, E.D., and POLLARD, T.D. (2003). Dynamic localization of myosin-I to endocytic structures in Acanthamoeba. Cell Motil. Cytoskeleton. 54, 29-40.
19. PARPAL, S., KARLSSON, M., THORN, H., and STRÅLFORS, P. (2001). Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor sub-strate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 276, 9670-9678.
20. ROBERTS, J., PALMA, E., SAZANI, P., ØRUM, H., CHO, M., and KOLE, R. (2006). Eff cient and persistent splice switching by sys-temically delivered LNA oligonucleotides in mice. Mol. Ther. 14, 471-475.
21. SABHARANJAK, S., SHARMA, P., PARTON, R.G., and MAYOR, S. (2002). GPI-anchored proteins are delivered to recycling endo-somes via a distinct cdc42-regulated, clathrin-independent pino-cytic pathway. Dev. Cell. 2, 411-423.
22. SAZANI, P., and KOLE, R. (2003). Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. J. Clin. Invest. 112, 481-486.
23. SONG, E., ZHU, P., LEE, S.K., CHOWDHURY, D., KUSSMAN, S., DYKXHOORN, D.M., FENG, Y., PALLISER, D., WEINER, D.B., SHANKAR, P., MARASCO, W.A., and LIEBERMAN, J. (2005). Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23, 709-717.
24. STEIN, C.A., BENIMETSKAYA, L., and MANI, S. (2005). Antisense strategies for oncogene inactivation. Semin. Oncol. 32, 563-572.
25. TOUYZ, R.M., YAO, G., QUINN, M.T., PAGANO, P.J., and SCHIFFRIN, E.L. (2005). p47phox associates with the cytoskeleton through cortactin in human vascular smooth muscle cells: role in NAD(P) H oxidase regulation by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 25, 512-518.
26. TURNER, J.J., ARZUMANOV, A.A., and GAIT, M.J. (2005). Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res. 33, 27-42.
27. URIARTE, S.M., JOG, N.R., LUERMAN, G.C., BHIMANI, S., WARD, R.A., and MCLEISH, K.R. (2009). Counterregulation of clathrin-mediated endocytosis by the actin and microt ubular cytoskeleton in human neutrophils. Am. J. Physiol., Cell Physiol. 296, C857-C867.
28. WHITEHEAD, K.A., LANGER, R., and ANDERSON, D.G. (2009). Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8, 129-138.